Studies on the emergence of resistance to lomefloxacin in vitro

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
M Kanematsu, D Greenwood

Abstract

The emergence of resistance to lomefloxacin, norfloxacin and ciprofloxacin was investigated in nalidixic acid sensitive and resistant urinary isolates by continuous turbidimetry. A decline in susceptibility was observed after a single exposure to each of the drugs, and further increments of resistance occurred during three sequential passages. Variants resistant to one quinolone were cross-resistant to the others. The level of resistance selected by norfloxacin in three of the five test strains was greater than that observed with lomefloxacin or ciprofloxacin. In experiments in a model of the treatment of bacterial cystitis, concentrations of lomefloxacin well within those readily achievable in urine suppressed growth of nalidixic acid sensitive and resistant strains for more than 20 h without causing any decline in susceptibility of surviving bacteria.

References

Dec 1, 1977·Antimicrobial Agents and Chemotherapy·D Greenwood, F O'Grady
Mar 1, 1978·The Journal of Antimicrobial Chemotherapy·D Greenwood, F O'Grady
Jul 6, 1985·Lancet·S T ChapmanD S Reeves
Apr 1, 1986·European Journal of Clinical Microbiology·F FollathH Reber
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·C H Teoh-ChanD Greenwood
Dec 1, 1988·The Journal of Antimicrobial Chemotherapy·R EdwardsD Greenwood
Jan 1, 1987·The Journal of Antimicrobial Chemotherapy·D I LimbR C Spencer
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·T HiroseS Mitsuhashi
Aug 1, 1973·The Journal of Infectious Diseases·D Greenwood, F O'Grady
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·J H TenneyG R Chippendale
Apr 1, 1984·The Journal of Antimicrobial Chemotherapy·D GreenwoodR Slack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.